Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the ...

Moffitt Cancer Center’s latest partnership with a biotech startup aims to change how solid tumors are treated.

The fact that we have a connection with this band, and that we have a connection through the institution that I run, it’s ...

Herbs, natural supplements, acupuncture, and a balanced diets are all great to implement during cancer treatment, but they ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Berkadia has arranged the sale of a 28.5-acre development site located within the master-planned community of Bexley in Land O’ Lakes, roughly 30 miles north of downtown Tampa. The Dinerstein Cos., in ...

RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, today announced its selection to join Lilly Gateway Labs (LGL) in San Diego, an innovation ...

Aims to advance next-gen immunotherapies targeting the dark proteome.

Utilising this theory could help manage the often-fatal problem of malignant cells becoming resistant to chemotherapy.

TAMPA, Fla. — Moffitt Cancer Center is training the future cancer researchers of America and they’re making sure underrepresented minority students are being trained in their labs. It’s part ...

Dr. Richard Munassi MD MBA is a serial Entrepreneur and investor. As Managing Director, Dr. Munassi leads both the CORE and ...

Last year, Agriculture Commissioner Wilton Simpson landed in the honorable mention category for Tampa Bay’s Most Powerful ...